September 27, 2018 | News

An Interview with Intract’s CEO: How Intract Is Helping Shape Microbiome-Based Therapies

Our CEO, Bill Lindsay, was recently interviewed by Anju Ghangurde from Scrip Intelligence (Informa plc)

This tied in with a stimulating panel discussion on External Innovation at BioAsia 2018 in Hyderabad

Learn what Bill had to say about the future of microbiome-based therapies, oral delivery of biologics and more!

Back to News